This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Internist's Role

LESLIE ROCHER, MD

Arch Intern Med. 1990;150(1):26-28.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The discovery and isolation of insulin earlier in this century proved a life-saving advance for many diabetics. But with this treatment new challenges emerged—the progressive systemic microvascular and macrovascular injuries that limit both the quality and duration of life of these patients.¹ Therefore, much attention has turned to the prevention, early diagnosis, and therapy of these vascular complications. One of these, diabetic nephropathy, while affecting only a minority of diabetics, is particularly devastating, for, while treatment exists, no cure is known. At end stage, these diabetics must undergo renal-replacement therapy with either dialysis, and its attendant intrusions on life-style and medical complications, or renal transplantation, also a lessthan-perfect remedy. Of the diverse causes of end-stage renal disease (ESRD), diabetes represents the fastest expanding subgroup. By 1988, 34% of individuals reaching ESRD in the United States were diabetic, in contrast with 21% of individuals 6 years earlier (P. Eggers, oral . . . [Full Text PDF of this Article]

Author Affiliations
Division of Nephrology William Beaumont Hospital 3601 W 13-Mile Rd Royal Oak, MI 48072-2803

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?